New pressures in solubility, targeting precision and injectable usability are forcing drug delivery to evolve across formulation, mechanism and delivery method. This In-Depth Focus explores the approaches beginning to reshape performance outcomes across the development pipeline.
- Mechanically targeted drug delivery for stroke: moving from clot centric care to collateral therapeutics
Here, drug delivery experts describe a novel shear activated nanoparticle aggregate (NPA) platform that applies precisely targeted stroke therapies using pathological haemodynamics.
- Dissolution enhancement via solid-dose delivery of lipid-based formulation
Tony Carpanzano
JRS Pharma
- Setting a new standard for Luer Lock syringe closure systems
Daniela Geiger
Vetter Pharma
Sponsored by JRS Pharma and Vetter Pharma
Download Now
No comments yet